HeartBeam (NASDAQ: BEAT), a medical technology company advancing cardiac care, has submitted a 510(k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram (“ECG”) synthesis software. The software is designed to assess cardiac rhythms and arrhythmias, including atrial fibrillation, atrial flutter, bradycardia, and tachycardia. The submission is supported by data from…
Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company advancing targeted antitumor virotherapies, will host an investor webinar on Feb. 5, 2025, at 4:15 p.m. ET. The event, organized by RedChip Companies, will feature CFO Andrew Jackson and CSO Antonio F. Santidrian, PharmD, PhD, discussing Calidi’s cell-based delivery platforms designed to enhance oncolytic virus-based cancer…
McEwen Mining (NYSE: MUX) (TSX: MUX) is positioned to benefit from the surging demand for crucial minerals in the AI industry. A recent article highlights this opportunity demonstrated in strategic moves taken by Isreal and the U.S. “The government in Israel has set up a new office based at the Defense Ministry. This office will superintend over the…
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems and the world’s first commercial supplier of quantum computers, has launched the Leap Quantum LaunchPad™ program to advance quantum computing application deployment. The initiative offers a three-month free trial granting access to D-Wave’s technology, including its Advantage™ quantum computers and Leap™ cloud service, along…
Massimo Group (NASDAQ: MAMO), a producer of powersports vehicles and pontoon boats, announced its participation in The Microcap Conference 2025, scheduled for Jan. 28-30 at the Borgata Hotel Spa & Casino in Atlantic City, N.J. Chief Financial Officer Dr. Yunhao Chen will host one-on-one investor meetings and deliver a live presentation during the event. To view…
Thumzup (NASDAQ: TZUP), a company at the forefront of modernizing the social media branding and marketing industry, recently announced its strategic expansion into South Florida. “This marks a milestone for the company as it moves to become a leader in digital marketing,” reads an article discussing Thumzup and its innovative platform, which enables individuals to…
FingerMotion (NASDAQ: FNGR), announced that it has been awarded contracts to equip emergency response vehicles with its Advanced Mobile Integrated Command and Communication Platform (“C2 Platform”) following a competitive tender process. Developed in collaboration with JiuGe Technology, a subsidiary, and SAIC Maxus, the C2 Platform integrates mobile, satellite, and private networks, enabling real-time, uninterrupted communication…
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) reported high-grade assay results from its definition drilling program at the Iska Iska silver-tin polymetallic project in Bolivia. Hole DSB-72 intersected 1.39% tin over 33m within a broader interval of 0.74% tin over 87m, alongside 24.48 g/t silver over 45m in the upper section. The tin mineralization is…
SuperCom (NASDAQ: SPCB), a global provider of e-Government, IoT, and cybersecurity solutions, has signed a contract with a U.S. multi-state electronic monitoring service provider, furthering its expansion in the U.S. market. This partnership will deploy SuperCom’s PureSecurity Suite into new and existing programs, starting with high-impact opportunities in the Northeastern United States and expanding to…
McEwen Mining (NYSE: MUX) (TSX: MUX) was featured in a recent article that discussed its positioning as a key player in the precious metals market while offering exposure to growth trends. “As gold continues to shine as a pillar of stability, investors seeking exposure to the precious metals sector should take a close look at McEwen…
Thumzup (NASDAQ: TZUP), an emerging leader in social media branding and marketing solutions, is looking to further expand its advertiser reach through strategic integrations with the two leading social media platforms, X (formerly Twitter) and TikTok. “The launch with X is already underway, and TikTok upcoming. These ambitious moves complement the company’s current integration with…
FingerMotion (NASDAQ: FNGR), posted $8.53 million in revenue for Q3 fiscal 2025, a 39% year-over-year increase driven by its Telecommunications Products & Services division. The SMS & MMS segment saw revenue jump to $44,457, compared to $7,900 in Q3 fiscal 2024, while Big Data revenue was $0, down from $5,584. Gross profit fell 30% to…
Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company specializing in targeted antitumor virotherapies, announced its abstract, “Development of a Systemic Enveloped Virotherapy for Targeting All Metastatic Sites,” has been accepted for presentation at the American Association for Cancer Research (“AACR”) Annual Meeting, April 25-30, 2025, in Chicago. The presentation will highlight Calidi’s proprietary RTNova…
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, announced that CEO Dr. Alan Baratz appeared on CNBC’s “The Exchange” on January 8th to address recent comments by NVIDIA CEO Jensen Huang regarding quantum computing’s readiness. Dr. Baratz clarified that D-Wave’s annealing quantum computing systems are already commercially available…
McEwen Mining (NYSE: MUX) (TSX: MUX) was highlighted in a recent article that discussed favorable positioning of the United States in the AI sector. “Sam Altman, the CEO of OpenAI, has voiced his confidence in President-elect Donald Trump supporting the AI sector and ensuring that America, together with its allies, retain pole position in this nascent…
Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company focused on targeted immunotherapies, has priced its public offering of 5,000,000 shares of common stock at $0.85 per share, with gross proceeds expected to total approximately $4.25 million before fees and expenses. The offering, exclusively placed by Ladenburg Thalmann & Co. Inc., is set to close…
Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”). The company recently secured a new $10 million debt facility, which enables the payoff of another higher…
Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), today announced that the FDA has accepted an updated protocol for the pivotal Phase 3 AD study, which is slated to begin in January 2025. In October 2024, the FDA…
SuperCom (NASDAQ: SPCB) has secured a contract with an Alabama government agency to deploy its advanced GPS tracking and domestic violence monitoring solutions, marking the company’s fifth state entry since August 2024 and its 10th U.S. contract in 60 days. The agreement includes the implementation of SuperCom’s PureSecurity GPS Tracking and PureProtect technologies, which feature real-time…